- Iodine Therapy
- Thyroxin Treatment
- Chemotherapy
- Cisplatin
- Doxorubicin
- Drugs
- Levothyroxine
- Radioiodine
Thyroid Cancer Treatment Market size was valued at USD 1,672.1 million in 2021, growing at a CAGR of 5.1% from 2022 to 2028. The global market provides a detailed overview and which can be segmented by treatment type, drugs, distribution channel, and region. By treatment type, the market has been segmented into iodine therapy, thyroxin treatment, and chemotherapy (cisplatin, doxorubicin)). By treatment type, the chemotherapy segment held the majority of the revenue share of the thyroid cancer treatment market in the historic period and is anticipated to have led the segment growth rate over the forecasted period due to an increase in the demand for chemotherapy in various types of cancer. By drugs, the thyroid cancer treatment market has been segmented into levothyroxine and radioiodine. By drugs, the radioiodine segment held the largest revenue share of the thyroid cancer treatment market in these current years and is expected to have the fastest growth rate over the forecasted period. By distribution channel, the market has been segmented into hospital pharmacies, retail pharmacies, and others. By treatment type, the chemotherapy segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to a high prescription rate. Key Development: In July 2022, Novartis AG, AstraZeneca Plc, and Pfizer Inc are among the leading companies in the thyroid cancer pipeline products market global data Plc.
Thyroid Cancer Treatment Market Summary
Study Period
2023-29
Base Year
2022
CAGR
5.1%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Thyroid Cancer Treatment Market Dynamics Drivers
The increasing prevalence of thyroid cancer globally, along with the rising investment in healthcare expenditure are the primary driver for the growth of the thyroid cancer treatment market. Furthermore, the increasing geriatric population and the growing middle-class population in emerging economies are on a global level further expected to fuel the market in current years. For instance, as per the data collected from the United Nations Department of Economic and Social Affairs, in 2020, the estimated elderly population aged above 65 accounted for 727 million and by 2050 the number is projected to get double nearly to 1,500 million.
North-America Got Significant Share
Thyroid Cancer Treatment Market
By region, North America is estimated to occupy the largest share of the global thyroid cancer treatment market in terms of revenue, owing to the rising healthcare investment, accompanied by the presence of leading healthcare service providers, and the growing number of cancer patients in the region. Apart from this, the countries in North America such as the United States are encouraging cancer care for cancer patients, which is further anticipated to contribute to the market growth in the region. As per the report published by the National Cancer Institute, in 2020, 1.8 million new cancer cases were reported in the United States. This increased rate of cancer is further expected to fuel the demand for thyroid cancer treatment products in North American countries.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Thyroid Cancer Treatment Market Segmentation
Treatment Type
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Geography
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
LOCATION
Geography
Frequently Asked Questions
Based on treatment type, the chemotherapy segment held the majority of the revenue share of the thyroid cancer treatment market in the historic period and is anticipated to have led the segment growth rate over the forecasted period due to an increase in the demand for chemotherapy in various types of cancer.
High cost of diagnosis, and unawareness among people in under-developed and developing countries.
The global thyroid cancer treatment market size is expected to be valued at USD 1,672.1 million in 2021.
North America is estimated to have the largest share of the global thyroid cancer treatment market in terms of revenue, owing to the rising healthcare investment, accompanied by the presence of leading healthcare service providers, and the growing number of cancer patients in the region.
[urltag url='request-table-of-content']
- Abbott Laboratories
- Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.,
- Siemens AG
- Bio Rad Laboratories Inc.
- GE Healthcare,
- Illumina, Inc.
- Koninklijke Philips N.V.
- Toshiba Medical Systems Corporation